{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T11:48:29Z","timestamp":1791373709930,"version":"4.3.1"},"reference-count":32,"publisher":"BMJ","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pathol"],"accepted":{"date-parts":[[2008,10,3]]},"published-print":{"date-parts":[[2009,1]]},"abstract":"<jats:p>Early results from the National Health Service Sickle Cell and Thalassaemia Screening programme covering the whole of England are reported following the implementation of the national newborn blood-spot screening programme. Of the 13 laboratories performing screening, 10 chose high-performance liquid chromatography as the first screen, with isoelectric focusing as the second confirmatory test. Screening results for April 2005 to March 2007 are presented and include data from all the laboratories screening newborns in England, and almost 1.2 million infants. The screen-positive results show a national birth prevalence of almost 1 in 2000. The birth prevalence in London is five times that of most of the rest of the country. Over 17\u200a000 carriers have been identified. Approximately seven per 1000 samples are reported as post-transfusion with wide ethnic category variation. Given the prevalence of the conditions, and coverage by ethnicity, 3\u20134 screen-positive cases could be missed each year. National implementation of newborn screening in England has increased the number of children identified with sickle cell disease, in many areas almost doubling the workload. Underascertainment of the condition has allowed a downplaying of the scale of need. It may also have contributed to infant mortality rates in urban areas as babies died without a diagnosis or treatment. The value of a co-ordinated national approach to policy development and implementation is emphasised by the English experience. The programme provides a model for Europe as well as other countries with significant minority populations, such as Canada. Potentially it also offers important lessons for Africa where the World Health Organization is supporting the introduction of newborn screening.<\/jats:p>","DOI":"10.1136\/jcp.2008.058859","type":"journal-article","created":{"date-parts":[[2008,12,22]],"date-time":"2008-12-22T15:05:56Z","timestamp":1229958356000},"page":"26-30","source":"Crossref","is-referenced-by-count":86,"title":["Implementation of universal newborn bloodspot screening for sickle cell disease and other clinically significant haemoglobinopathies in England: screening results for 2005\u20137"],"prefix":"10.1136","volume":"62","author":[{"given":"A","family":"Streetly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Latinovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Henthorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2008,12,22]]},"reference":[{"key":"2025120518513426000_62.1.26.1","unstructured":"Department of Health. The NHS Plan, July 2000: a plan for investment, a plan for reform. http:\/\/www.connectingforhealth.nhs.uk\/resources\/policyandguidance (accessed 30 October 2008)."},{"key":"2025120518513426000_62.1.26.2","unstructured":"Department of Health. Report of a working party of the standing medical advisory committee on sickle cell, thalassaemia and other haemoglobinopathies (SMAC report). London: HMSO, 1993."},{"key":"2025120518513426000_62.1.26.3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.320.7246.1353"},{"key":"2025120518513426000_62.1.26.4","unstructured":"Anionwu E Atkin K . The politics of sickle cell and thalassaemia. Milton Keynes: Open University Press, 2001."},{"key":"2025120518513426000_62.1.26.5","doi-asserted-by":"crossref","unstructured":"Zeuner D Ades AE Karnon J . Antenatal and neonatal haemoglobinopathy screening in the UK: review and economic analysis. NIHR Health Technology Assessment Programme. Volume 3, no. 11. 1999. http:\/\/www.hta.ac.uk\/project.asp?PjtId\u200a=\u200a915 (accessed 30 October 2008).","DOI":"10.3310\/hta3110"},{"key":"2025120518513426000_62.1.26.6","doi-asserted-by":"crossref","unstructured":"Davies SC Cronin E Gill M . Screening for sickle cell disease and thalassaemia: a systematic review with supplementary research. NIHR Health Technology Assessment Programme. Volume 4, no. 3. 2000. http:\/\/www.hta.ac.uk\/project.asp?PjtId\u200a=\u200a916 (accessed 30 October 2008).","DOI":"10.3310\/hta4030"},{"key":"2025120518513426000_62.1.26.7","unstructured":"National Health Service Sickle Cell and Thalassaemia Screening Programme. International workshop on haemoglobinopathy screening to inform the screening developments in England. 2001. http:\/\/sct.screening.nhs.uk\/events.htm#IntlWksp01 (accessed 30 October 2008)."},{"key":"2025120518513426000_62.1.26.8","unstructured":"Wilson JMG Jungner G . Principles and practice of screening for disease. Paper no. 34. Geneva: World Health Organization, 1968."},{"key":"2025120518513426000_62.1.26.9","unstructured":"Department of Health. Appendix C: The UK National Screening Committee Criteria for appraising the viability, effectiveness and appropriateness of a screening programme. In: Second report of the UK National Screening Committee, 2001;26\u20137. http:\/\/www.nsc.nhs.uk\/pdfs\/secondreport.pdf (accessed 30 October 2008)."},{"key":"2025120518513426000_62.1.26.10","unstructured":"NHS Sickle Cell and Thalassaemia Screening Programme. Laboratory handbook. 1st edn. 2006. http:\/\/sct.screening.nhs.uk\/Lab_Policy.htm (accessed 30 October 2008)."},{"key":"2025120518513426000_62.1.26.11","unstructured":"Human Genetics Commission. Making babies: reproductive decisions and genetic technologies. London: Human Genetics Commission, 2006. http:\/\/www.hgc.gov.uk\/UploadDocs\/DocPub\/Document\/Making%20Babies%20Report%20-%20final%20pdf.pdf (accessed 30 October 2008)."},{"key":"2025120518513426000_62.1.26.12","unstructured":"Lin K Barton M . Screening for hemoglobinopathies in newborns: reaffirmation update for the US Preventive Services Task Force. Evidence Synthesis No. 52. Rockville, MD: Agency for Healthcare Research and Quality, 2007. http:\/\/www.ahrq.gov\/clinic\/serfiles.htm#sicklecell, (accessed 30 October 2008)."},{"key":"2025120518513426000_62.1.26.13","unstructured":"National Health Service Sickle Cell and Thalassaemia Screening Programme A survey of haemoglobinopathy screening policy and practice in England. 2001. http:\/\/sct.screening.nhs.uk\/publications.htm#Survey (accessed 30 October 2008)."},{"key":"2025120518513426000_62.1.26.14","unstructured":"NHS Sickle Cell and Thalassaemia Screening Programme. Regional mapping reports. 2003\u20135. http:\/\/sct.screening.nhs.uk\/publications.htm#Mapping (accessed 30 October 2008)."},{"key":"2025120518513426000_62.1.26.15","unstructured":"United Kingdom National External Quality Assessment Service. http:\/\/www.ukneqas.org.uk (accessed 30 October 2008)."},{"key":"2025120518513426000_62.1.26.16","unstructured":"NHS Screening. Antenatal and Newborn Screening Programme publications. http:\/\/www.screening.nhs.uk\/anpublications\/index.htm (accessed 30 October 2008)."},{"key":"2025120518513426000_62.1.26.17","unstructured":"NHS Sickle Cell and Thalassaemia Screening Programme. Results of Newborn Blood-Spot screening Carrier of a sickle cell gene \u2013 sometimes called trait Hb AS. http:\/\/sct.screening.nhs.uk\/publications.htm#NBSickleCarrier (accessed 30 October 2008)."},{"key":"2025120518513426000_62.1.26.18","unstructured":"NHS Sickle Cell and Thalassaemia Screening Programme. Results of Newborn Blood-Spot screening Carrier of a gene for an unusual haemoglobin \u2013 sometimes called trait Hb AC, Hb AD, Hb AOArab, Hb AE, Hb A Lepore. 2007. http:\/\/sct.screening.nhs.uk\/publications.htm#NBOtherCarrier (accessed 30 October 2008)."},{"key":"2025120518513426000_62.1.26.19","unstructured":"NHS Sickle Cell and Thalassaemia Screening Programme. NHS Sickle Cell and Thalassaemia Screening Programme \u2013 Standards for the linked Antenatal and Newborn Screening Programme. 2006. http:\/\/sct.screening.nhs.uk\/AimsObject.htm#ProgStandards (accessed 30 October 2008)."},{"key":"2025120518513426000_62.1.26.20","unstructured":"UK Forum on Haemoglobin Disorders. Sickle Cell Disease in Childhood: standards and guidelines for clinical care. NHS Sickle Cell and Thalassaemia Screening Programme 2006. http:\/\/sct.screening.nhs.uk\/publications.htm#ClinicalCareGuidelines (accessed 30 October 2008)."},{"key":"2025120518513426000_62.1.26.21","doi-asserted-by":"publisher","DOI":"10.1080\/00365510601046557"},{"key":"2025120518513426000_62.1.26.22","unstructured":"NHS Antenatal and Newborn Screening Programmes. PEGASUS for public health and policymakers. http:\/\/www.pegasus.nhs.uk\/phnpolicy\/menu.php (accessed 30 October 2008)."},{"key":"2025120518513426000_62.1.26.23","doi-asserted-by":"publisher","DOI":"10.1258\/jms.2008.007063"},{"key":"2025120518513426000_62.1.26.24","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/bmj.309.6951.372","article-title":"The Metabolic (\u201cGuthrie\u201d) Neonatal Screening Programme: variation in coverage by ethnic group: possible explanations and implications.","volume":"309","author":"Streetly","year":"1994","journal-title":"BMJ"},{"key":"2025120518513426000_62.1.26.25","first-page":"52","article-title":"Geographic differences in mortality of young children with sickle cell disease in the United States.","volume":"112","author":"Davis","year":"1997","journal-title":"Public Health Rep"},{"key":"2025120518513426000_62.1.26.26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.300.6721.371"},{"key":"2025120518513426000_62.1.26.27","doi-asserted-by":"crossref","unstructured":"Weatherall D Akinyanju O Oliveri N . Inherited disorders of haemoglobin. In: Jamison JT, Breman JG, Measham AR, et al. eds. Disease control priorities in developing countries. 2nd edn. New York: Oxford University Press, 2006:663\u201380. http:\/\/www.dcp2.org\/pubs\/DCP (accessed 30 October 2008).","DOI":"10.1596\/978-0-8213-6179-5\/Chpt-34"},{"key":"2025120518513426000_62.1.26.28","unstructured":"Christianson A Howson CP Modell B . March of Dimes global report on birth defects. The hidden toll of dying and disabled children. White Plains, New York: March of Dimes Birth Defects Foundation, 2006. http:\/\/www.marchofdimes.com\/professionals\/871_18587.asp (accessed 30 October 2008)."},{"key":"2025120518513426000_62.1.26.29","unstructured":"World Health Organization. Sickle-cell anaemia: report by the secretariat. 2006. http:\/\/www.who.int\/gb\/ebwha\/pdf_files\/WHA59\/A59_9-en.pdf (accessed 30 October 2008)."},{"key":"2025120518513426000_62.1.26.30","unstructured":"Antenatal and Newborn Screening Programme. PEGASUS Support for Public Health and Policymakers. http:\/\/www.pegasus.nhs.uk\/phnpolicy\/nhs.pdf . (accessed 30 October 2008)."},{"key":"2025120518513426000_62.1.26.31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05646.x"},{"key":"2025120518513426000_62.1.26.32","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2007.088682"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jcp.2008.058859","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T02:51:44Z","timestamp":1764989504000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jcp.2008.058859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,22]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2008,12,22]]},"published-print":{"date-parts":[[2009,1]]}},"alternative-id":["10.1136\/jcp.2008.058859"],"URL":"https:\/\/doi.org\/10.1136\/jcp.2008.058859","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"value":"0021-9746","type":"print"},{"value":"1472-4146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,22]]}}}